Related references
Note: Only part of the references are listed.MiR-137-3p Inhibits Colorectal Cancer Cell Migration by Regulating a KDM1A-Dependent Epithelial-Mesenchymal Transition
Xiaoling Ding et al.
DIGESTIVE DISEASES AND SCIENCES (2021)
KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer
Mei Zhou et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
miR-1231 Is Downregulated in Prostate Cancer with Prognostic and Functional Implications
Yitao Wang et al.
ONCOLOGY RESEARCH AND TREATMENT (2020)
Expanding the Role of the Histone Lysine-Specific Demethylase LSD1 in Cancer
Barbara Majello et al.
CANCERS (2019)
Examining the biomarkers and molecular mechanisms of medulloblastoma based on bioinformatics analysis
Biao Yang et al.
ONCOLOGY LETTERS (2019)
High impact of miRNA-4521 on FOXM1 expression in medulloblastoma
Daniel Senfter et al.
CELL DEATH & DISEASE (2019)
Prognostic relevance of miR-137 and its liver microenvironment regulatory target gene AFM in hepatocellular carcinoma
Qian Wei et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
MicroRNA-137 Inhibits Cancer Progression by Targeting Del-1 in Triple-Negative Breast Cancer Cells
Soo Jung Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway
Dawei Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
MiR-137 functions as a tumor suppressor in pancreatic cancer by targeting MRGBP
Feng Ding et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation
Wei Zhang et al.
LABORATORY INVESTIGATION (2018)
miR-137 suppresses proliferation, migration and invasion of colon cancer cell lines by targeting TCF4
Wei-Ping Bi et al.
ONCOLOGY LETTERS (2018)
Impact of miRNA-mRNA Profiling and Their Correlation on Medulloblastoma Tumorigenesis
Vinod Kumar et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Clinical and pre-clinical utility of genomics in medulloblastoma
Carolina Nor et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2018)
Pharmacological Inhibition of LSD1 for Cancer Treatment
Guan-Jun Yang et al.
MOLECULES (2018)
Challenges and Recent Advances in Medulloblastoma Therapy
Vinod Kumar et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
被撤回的出版物: MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2 (Retracted article. See vol. 22, 2021)
Qiong Feng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis
Julia Alejandra Pezuk et al.
CHILDS NERVOUS SYSTEM (2017)
Treatment of medulloblastoma in children and adolescents
Nelci Zanon Collange et al.
Revista da Associacao Medica Brasileira (2016)
miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C
Yantao Du et al.
TUMOR BIOLOGY (2016)
miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart
Bianca C. Bernardo et al.
FUTURE MEDICINAL CHEMISTRY (2015)
MiR-383 is Downregulated in Medulloblastoma and Targets Peroxiredoxin 3 (PRDX3)
Kay Ka-Wai Li et al.
BRAIN PATHOLOGY (2013)
The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma
Kristian W. Pajtler et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
Share Paper
